PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.06%
Revenue growth above 1.5x 3391.T's 2.16%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
3.06%
Gross profit growth at 75-90% of 3391.T's 3.45%. Bill Ackman would demand operational improvements to match competitor gains.
-44.76%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-7.53%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-34.48%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-34.48%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-34.48%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
45.54%
10Y revenue/share CAGR under 50% of 3391.T's 219.40%. Michael Burry would suspect a lasting competitive disadvantage.
54.62%
5Y revenue/share CAGR similar to 3391.T's 56.27%. Walter Schloss might see both companies benefiting from the same mid-term trends.
25.47%
3Y revenue/share CAGR similar to 3391.T's 26.25%. Walter Schloss would assume both companies experience comparable short-term cycles.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
62.16%
Below 50% of 3391.T's 216.84%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
72.44%
5Y net income/share CAGR above 1.5x 3391.T's 2.06%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-3.19%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
187.26%
10Y equity/share CAGR at 75-90% of 3391.T's 213.82%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
123.92%
5Y equity/share CAGR above 1.5x 3391.T's 64.43%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
56.65%
3Y equity/share CAGR above 1.5x 3391.T's 31.67%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-21.43%
Cut dividends over 10 years while 3391.T stands at 395761.09%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
57.14%
5Y dividend/share CAGR above 1.5x 3391.T's 30.47%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
22.22%
3Y dividend/share CAGR above 1.5x 3391.T's 9.87%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
16.28%
AR growth is negative/stable vs. 3391.T's 34.41%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
8.26%
Inventory growth well above 3391.T's 1.98%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.92%
Asset growth well under 50% of 3391.T's 14.58%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
3.38%
BV/share growth above 1.5x 3391.T's 1.31%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
75.68%
We have some new debt while 3391.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
6.04%
SG&A growth well above 3391.T's 9.75%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.